118 related articles for article (PubMed ID: 21952708)
1. Protection of estrogen in portal hypertension gastropathy: an experimental model.
Morgan-Martins MI; Jacques SI; Hartmann RM; Marques CM; Marroni CA; Marroni NP
Arq Gastroenterol; 2011; 48(3):211-6. PubMed ID: 21952708
[TBL] [Abstract][Full Text] [Related]
2. Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy.
Marques C; Mauriz JL; Simonetto D; Marroni CA; Tuñon MJ; González-Gallego J; Marrón NP
Ann Hepatol; 2011; 10(4):531-9. PubMed ID: 21911895
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats.
Licks F; Marques C; Zetler C; Martins MI; Marroni CA; Marroni NP
Ann Hepatol; 2014; 13(3):370-7. PubMed ID: 24756013
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.
Marques C; Licks F; Zattoni I; Borges B; de Souza LE; Marroni CA; Marroni NP
World J Gastroenterol; 2013 Jul; 19(28):4464-74. PubMed ID: 23901221
[TBL] [Abstract][Full Text] [Related]
5. Estrogen improves the hyperdynamic circulation and hyporeactivity of mesenteric arteries by alleviating oxidative stress in partial portal vein ligated rats.
Zhang B; Zhang CG; Zhou QB; Chen W; Wu ZY
World J Gastroenterol; 2013 Oct; 19(40):6863-8. PubMed ID: 24187462
[TBL] [Abstract][Full Text] [Related]
6. Glutamine prevents oxidative stress in a model of portal hypertension.
Zabot GP; Carvalhal GF; Marroni NP; Licks F; Hartmann RM; da Silva VD; Fillmann HS
World J Gastroenterol; 2017 Jul; 23(25):4529-4537. PubMed ID: 28740341
[TBL] [Abstract][Full Text] [Related]
7. Gastropathy and defense mechanisms in common bile duct ligated portal hypertensive rats.
Kaur S; Kaur U; Tandon C; Dhawan V; Ganguly NK; Majumdar S
Mol Cell Biochem; 2000 Jan; 203(1-2):79-85. PubMed ID: 10724335
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
Licks F; Hartmann RM; Marques C; Schemitt E; Colares JR; Soares Mdo C; Reys J; Fisher C; da Silva J; Marroni NP
World J Gastroenterol; 2015 Nov; 21(43):12351-60. PubMed ID: 26604642
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats.
Yokoyama Y; Wawrzyniak A; Sarmadi AM; Baveja R; Gruber HE; Clemens MG; Zhang JX
J Gastroenterol Hepatol; 2006 Oct; 21(10):1567-74. PubMed ID: 16928218
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant role of heme oxygenase-1 in prehepatic portal hypertensive rats.
Gonzales S; Perez MJ; Perazzo JC; Tomaro ML
World J Gastroenterol; 2006 Jul; 12(26):4149-55. PubMed ID: 16830363
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal prostaglandin E(2) generation in various organs during evolution of experimental portal hypertension.
Ackerman Z; Karmeli F; Rachmilewitz D
Prostaglandins Leukot Essent Fatty Acids; 2002 Oct; 67(4):197-201. PubMed ID: 12401432
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Reiberger T; Angermayr B; Schwabl P; Rohr-Udilova N; Mitterhauser M; Gangl A; Peck-Radosavljevic M
J Hepatol; 2009 Nov; 51(5):865-73. PubMed ID: 19726100
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T
Adv Med Sci; 2022 Mar; 67(1):154-162. PubMed ID: 35272246
[TBL] [Abstract][Full Text] [Related]
14. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
15. Gastric mucosal resistance to acute injury in experimental portal hypertension.
Calatayud S; Ramírez MC; Sanz MJ; Moreno L; Hernández C; Bosch J; Piqué JM; Esplugues JV
Br J Pharmacol; 2001 Jan; 132(1):309-17. PubMed ID: 11156591
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antioxidant and anti-inflammatory action of N-acetylcysteine in portal hypertensive gastropathy in rats.
Licks F; Minuzzo Hartmann R; Schemitt E; Raskopf Colares J; Marques C; Fillmann H; Possa Marroni N
Hepatol Forum; 2022 May; 3(2):51-56. PubMed ID: 35783478
[TBL] [Abstract][Full Text] [Related]
17. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
18. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
[TBL] [Abstract][Full Text] [Related]
19. Successful hepatic grafting after partial portal vein ligation in the rat: complete reversal of hemodynamic abnormalities.
Zhang XY; Kuznetsova LV; Zimmermann A; Wheatley AM
Transplantation; 2000 Jan; 69(1):3-10. PubMed ID: 10653371
[TBL] [Abstract][Full Text] [Related]
20. CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATS.
Bertoldi AS; Guetter CR; Coltro GA; Vosgerau LM; Brighenti LMV; Fauat NI; Kubrusly FB; Marques CAM; Kubrusly LF
Arq Bras Cir Dig; 2020; 33(3):e1525. PubMed ID: 33331427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
